In this episode, rheumatologist John Fitzgerald, MD, and nurse practitioner Wendy Wright, DNP, discuss new treatment guidelines and how the collaboration between primary care and rheumatology can improve both acute and long-term management of gout.

In this episode, rheumatologists Patricia Katz and Alfred Kim and neurologist Daniel Barone discuss the prevalence of sleep disorders in rheumatic diseases and how collaboration between the specialties can improve diagnosis and care for patients.

Rheumatologists Latika Gupta and Mrinalini Dey discuss findings of the COVAD study describing adverse events associated with the COVID-19 vaccines among patients with autoimmune rheumatic diseases, including inflammatory myopathies.

Shilpa Venkatachalam, PhD, and Shubhasree Banerjee, MD, evaluate the factors associated with COVID-19 vaccine uptake and hesitancy among patients with autoimmune rheumatic diseases, and the importance of tailored messaging and communication between patient and provider.

In this episode, clinicians discuss the global challenges and opportunities in rheumatology research and the impact of collaboration and partnerships.

In this episode of Rheum Advisor on Air, Drs Allan Gibofsky and David Goldberg discuss legal considerations in the practice of telemedicine.

In recognition of Arthritis Awareness Month and Gout Awareness Day, Angelo Gaffo, MD, talks about creating awareness and provides a deeper insight into the prevalence and impact of gout among women.

Don Goldenberg, MD, provides an overview of the various aspects of chronic pain in rheumatology and the inaccurate interchangeability of the terms “fibromyalgia” and “central pain sensitization.” Deeba Minhas, MD, weighs in on addressing the systemic biases in chronic pain.

Beth Jonas, MD, discusses the various aspects “burnout” among the rheumatology workforce, with an emphasis on the effect of the COVID-19 pandemic on the mental health of rheumatologists.

In light of Rare Disease Day 2022, pediatric rheumatologist Emily von Scheven, MD, and a parent of a pediatric patient with rheumatic disease discuss the various aspects in the diagnosis and management of rare pediatric rheumatologic diseases.

In this episode, neurologist Michael Kornberg, MD, and rheumatologist Laura C. Cappelli, MD, speak with us about how to improve the management of patients with rheumatologic conditions with neurologic manifestations.

In this episode of the ACR 2021 podcast series, Dr Shilpa Venkatachalam and Dr Betty Hsiao discuss the importance of the patient voice and perspective in rheumatology research and practice.

In this episode of the Rheumatology Advisor ACR 2021 podcast series, Ada Kumar, MD, and Suneet Grewal, MD, discuss some of the important and clinically meaningful research presented at the meeting.

Karen Costenbader, MD, provides a roundup of all the exciting and compelling news and research in lupus, as presented at the ACR Convergence 2021.

In this episode, Mara Becker, MD, highlights the importance of collaboration between ophthalmology and rheumatology for the management of adults with juvenile idiopathic arthritis-associated uveitis.

Tracy Frech, MD, provides a deeper insight into the compelling and clinically meaningful research in scleroderma, as presented at the ACR Convergence 2021.

In the first episode of the ACR Convergence 2021 podcast series, Iris Navarro-Millán, MD, discusses the drivers of health care disparities in rheumatology, including race, ethnicity, and social determinants of health.

Season 2 of Rheum Advisor on Air, the official podcast of Rheumatology Advisor, is set to kick off with the ACR Convergence 2021 series, followed by expert perspectives on emerging topics in rheumatology.

Mary Crow, MD, and Christele Felix, a patient with lupus, each provide their perspectives on the recent FDA approval of anifrolumab for SLE treatment.

In this episode, Swati Deshmukh, MD, talks about the postacute symptoms of COVID-19, including musculoskeletal complications, among “COVID long haulers”, with a focus on patients with rheumatologic disease.

Toby Maher, MD, describes the increased prevalence of lung manifestations in scleroderma and the need for routine screening among these patients.

In this episode of the EULAR 2021 series, Dr Elena Nikiphorou highlights the role of diet in rheumatic and musculoskeletal diseases and what clinicians should tell their patients in this regard.

In this episode of the EULAR 2021 Virtual Congress series, Dr Jeffrey Sparks and Dr Zachary Wallace provide further insight into their study about DMARD use and COVID-19 outcomes in rheumatoid arthritis.

In this episode, dermatologist Joel Gelfand, MD, and rheumatologist Alexis Ogdie, MD, provide deeper insight into the overlap and transition of care between patients with psoriasis and PsA.

Karen Onel, MD, Nayimisha Balmuri, MD, and Jacob Spitznagle, MD, speak with us about the ethics of sex/gender assessment in a pediatric rheumatology population.

We’re discussing the CARRA registry with Yukiko Kimura, MD, and the COVID-19 Global Rheumatology Alliance with Pedro Machado, MD.

In this episode, Michael George, MD, talks to us about ArthritisPower, Jeff Greenberg, MD, discusses the work of CorEvitas, and Christie Bartels, MD, provides further insight into the ACR’s RISE Registry.

Shereen Mahmood, MD, and Irene Blanco, MD, provide insight into the gender gap and existing inequities among women in academic rheumatology.

This episode features Nehad Soloman, MD, who discusses the implications of the fictional depictions of gout in film and television and how providers can address this.

Peter Grayson, MD, of the NIH tells us the story behind the discovery of the new inflammatory syndrome, VEXAS, and the importance of research at a molecular level in rheumatology.